HEADER MEMBRANE PROTEIN 04-MAY-19 6OUG TITLE STRUCTURE OF DRUG-RESISTANT V27A MUTANT OF THE INFLUENZA M2 PROTON TITLE 2 CHANNEL BOUND TO SPIROADAMANTYL AMINE INHIBITOR, TM + CYTOSOLIC HELIX TITLE 3 CONSTRUCT COMPND MOL_ID: 1; COMPND 2 MOLECULE: MATRIX PROTEIN 2; COMPND 3 CHAIN: A, B, C, D, E, F, G, H; COMPND 4 SYNONYM: PROTON CHANNEL PROTEIN M2; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS (STRAIN A/MEMPHIS/1/1971 SOURCE 4 H3N2); SOURCE 5 ORGANISM_TAXID: 383586 KEYWDS VIRAL PROTEIN, PROTON CHANNEL, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.L.THOMASTON,L.LIU,W.F.DEGRADO REVDAT 3 11-OCT-23 6OUG 1 REMARK REVDAT 2 19-FEB-20 6OUG 1 JRNL REVDAT 1 15-JAN-20 6OUG 0 JRNL AUTH J.L.THOMASTON,A.KONSTANTINIDI,L.LIU,G.LAMBRINIDIS,J.TAN, JRNL AUTH 2 M.CAFFREY,J.WANG,W.F.DEGRADO,A.KOLOCOURIS JRNL TITL X-RAY CRYSTAL STRUCTURES OF THE INFLUENZA M2 PROTON CHANNEL JRNL TITL 2 DRUG-RESISTANT V27A MUTANT BOUND TO A SPIRO-ADAMANTYL AMINE JRNL TITL 3 INHIBITOR REVEAL THE MECHANISM OF ADAMANTANE RESISTANCE. JRNL REF BIOCHEMISTRY V. 59 627 2020 JRNL REFN ISSN 0006-2960 JRNL PMID 31894969 JRNL DOI 10.1021/ACS.BIOCHEM.9B00971 REMARK 2 REMARK 2 RESOLUTION. 3.01 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.11.1_2575: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.01 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 122.38 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 3.550 REMARK 3 COMPLETENESS FOR RANGE (%) : 85.3 REMARK 3 NUMBER OF REFLECTIONS : 5431 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.285 REMARK 3 R VALUE (WORKING SET) : 0.273 REMARK 3 FREE R VALUE : 0.301 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 268 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 3.1180 - 3.0100 0.69 2115 123 0.2744 0.4859 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.000 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 36.510 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2075 REMARK 3 ANGLE : 0.831 2842 REMARK 3 CHIRALITY : 0.807 372 REMARK 3 PLANARITY : 0.004 328 REMARK 3 DIHEDRAL : 13.255 661 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6OUG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-MAY-19. REMARK 100 THE DEPOSITION ID IS D_1000240218. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-MAY-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1158 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6417 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 122.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 12.50 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.7900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.240 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6BMZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.04M SODIUM CHLORIDE, 0.04M TRIS PH REMARK 280 8.0, 27% V/V PEG 350 MME, SPIROADAMANTYL AMINE INHIBITOR, REMARK 280 LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 24.71000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.69000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.71000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 24.69000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8140 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -38.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4500 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8270 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 21 REMARK 465 HIS A 57 REMARK 465 GLY A 58 REMARK 465 LEU A 59 REMARK 465 LYS A 60 REMARK 465 ARG A 61 REMARK 465 ASP B 21 REMARK 465 SER B 22 REMARK 465 SER B 23 REMARK 465 HIS B 57 REMARK 465 GLY B 58 REMARK 465 LEU B 59 REMARK 465 LYS B 60 REMARK 465 ARG B 61 REMARK 465 ASP C 21 REMARK 465 SER C 22 REMARK 465 HIS C 57 REMARK 465 GLY C 58 REMARK 465 LEU C 59 REMARK 465 LYS C 60 REMARK 465 ARG C 61 REMARK 465 ASP D 21 REMARK 465 SER D 22 REMARK 465 HIS D 57 REMARK 465 GLY D 58 REMARK 465 LEU D 59 REMARK 465 LYS D 60 REMARK 465 ARG D 61 REMARK 465 ASP E 21 REMARK 465 SER E 22 REMARK 465 HIS E 57 REMARK 465 GLY E 58 REMARK 465 LEU E 59 REMARK 465 LYS E 60 REMARK 465 ARG E 61 REMARK 465 ASP F 21 REMARK 465 SER F 22 REMARK 465 HIS F 57 REMARK 465 GLY F 58 REMARK 465 LEU F 59 REMARK 465 LYS F 60 REMARK 465 ARG F 61 REMARK 465 ASP G 21 REMARK 465 SER G 22 REMARK 465 HIS G 57 REMARK 465 GLY G 58 REMARK 465 LEU G 59 REMARK 465 LYS G 60 REMARK 465 ARG G 61 REMARK 465 ASP H 21 REMARK 465 SER H 22 REMARK 465 GLY H 58 REMARK 465 LEU H 59 REMARK 465 LYS H 60 REMARK 465 ARG H 61 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 51 CG1 CG2 CD1 REMARK 470 TYR A 52 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 53 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 54 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE A 55 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 56 CG CD OE1 OE2 REMARK 470 LYS B 49 CG CD CE NZ REMARK 470 ILE B 51 CG1 CG2 CD1 REMARK 470 TYR B 52 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG B 53 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 54 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE B 55 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU B 56 CG CD OE1 OE2 REMARK 470 PHE C 47 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ILE C 51 CG1 CG2 CD1 REMARK 470 TYR C 52 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG C 53 CG CD NE CZ NH1 NH2 REMARK 470 PHE C 54 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE C 55 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU C 56 CG CD OE1 OE2 REMARK 470 LYS D 49 CG CD CE NZ REMARK 470 ILE D 51 CG1 CG2 CD1 REMARK 470 TYR D 52 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG D 53 CG CD NE CZ NH1 NH2 REMARK 470 PHE D 54 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE D 55 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU D 56 CG CD OE1 OE2 REMARK 470 LYS E 49 CG CD CE NZ REMARK 470 ILE E 51 CG1 CG2 CD1 REMARK 470 TYR E 52 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG E 53 CG CD NE CZ NH1 NH2 REMARK 470 PHE E 54 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE E 55 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU E 56 CG CD OE1 OE2 REMARK 470 ILE F 51 CG1 CG2 CD1 REMARK 470 TYR F 52 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG F 53 CG CD NE CZ NH1 NH2 REMARK 470 PHE F 54 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE F 55 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU F 56 CG CD OE1 OE2 REMARK 470 TYR G 52 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG G 53 CG CD NE CZ NH1 NH2 REMARK 470 PHE G 54 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE G 55 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU G 56 CG CD OE1 OE2 REMARK 470 ILE H 51 CG1 CG2 CD1 REMARK 470 TYR H 52 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG H 53 CG CD NE CZ NH1 NH2 REMARK 470 PHE H 54 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE H 55 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU H 56 CG CD OE1 OE2 REMARK 470 HIS H 57 CG ND1 CD2 CE1 NE2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E01 D 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E01 E 101 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6NV1 RELATED DB: PDB REMARK 900 INFLUENZA A M2 TM V27A BOUND TO SPIROADAMANTYL AMINE INHIBITOR REMARK 900 RELATED ID: 6BMZ RELATED DB: PDB REMARK 900 INFLUENZA A M2 TM WT BOUND TO SPIROADAMANTYL AMINE INHIBITOR DBREF 6OUG A 21 61 UNP Q3YPZ4 M2_I71A1 21 61 DBREF 6OUG B 21 61 UNP Q3YPZ4 M2_I71A1 21 61 DBREF 6OUG C 21 61 UNP Q3YPZ4 M2_I71A1 21 61 DBREF 6OUG D 21 61 UNP Q3YPZ4 M2_I71A1 21 61 DBREF 6OUG E 21 61 UNP Q3YPZ4 M2_I71A1 21 61 DBREF 6OUG F 21 61 UNP Q3YPZ4 M2_I71A1 21 61 DBREF 6OUG G 21 61 UNP Q3YPZ4 M2_I71A1 21 61 DBREF 6OUG H 21 61 UNP Q3YPZ4 M2_I71A1 21 61 SEQADV 6OUG ALA A 27 UNP Q3YPZ4 VAL 27 ENGINEERED MUTATION SEQADV 6OUG SER A 50 UNP Q3YPZ4 CYS 50 ENGINEERED MUTATION SEQADV 6OUG ALA B 27 UNP Q3YPZ4 VAL 27 ENGINEERED MUTATION SEQADV 6OUG SER B 50 UNP Q3YPZ4 CYS 50 ENGINEERED MUTATION SEQADV 6OUG ALA C 27 UNP Q3YPZ4 VAL 27 ENGINEERED MUTATION SEQADV 6OUG SER C 50 UNP Q3YPZ4 CYS 50 ENGINEERED MUTATION SEQADV 6OUG ALA D 27 UNP Q3YPZ4 VAL 27 ENGINEERED MUTATION SEQADV 6OUG SER D 50 UNP Q3YPZ4 CYS 50 ENGINEERED MUTATION SEQADV 6OUG ALA E 27 UNP Q3YPZ4 VAL 27 ENGINEERED MUTATION SEQADV 6OUG SER E 50 UNP Q3YPZ4 CYS 50 ENGINEERED MUTATION SEQADV 6OUG ALA F 27 UNP Q3YPZ4 VAL 27 ENGINEERED MUTATION SEQADV 6OUG SER F 50 UNP Q3YPZ4 CYS 50 ENGINEERED MUTATION SEQADV 6OUG ALA G 27 UNP Q3YPZ4 VAL 27 ENGINEERED MUTATION SEQADV 6OUG SER G 50 UNP Q3YPZ4 CYS 50 ENGINEERED MUTATION SEQADV 6OUG ALA H 27 UNP Q3YPZ4 VAL 27 ENGINEERED MUTATION SEQADV 6OUG SER H 50 UNP Q3YPZ4 CYS 50 ENGINEERED MUTATION SEQRES 1 A 41 ASP SER SER ASP PRO LEU ALA VAL ALA ALA SER ILE ILE SEQRES 2 A 41 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 A 41 PHE PHE LYS SER ILE TYR ARG PHE PHE GLU HIS GLY LEU SEQRES 4 A 41 LYS ARG SEQRES 1 B 41 ASP SER SER ASP PRO LEU ALA VAL ALA ALA SER ILE ILE SEQRES 2 B 41 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 B 41 PHE PHE LYS SER ILE TYR ARG PHE PHE GLU HIS GLY LEU SEQRES 4 B 41 LYS ARG SEQRES 1 C 41 ASP SER SER ASP PRO LEU ALA VAL ALA ALA SER ILE ILE SEQRES 2 C 41 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 C 41 PHE PHE LYS SER ILE TYR ARG PHE PHE GLU HIS GLY LEU SEQRES 4 C 41 LYS ARG SEQRES 1 D 41 ASP SER SER ASP PRO LEU ALA VAL ALA ALA SER ILE ILE SEQRES 2 D 41 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 D 41 PHE PHE LYS SER ILE TYR ARG PHE PHE GLU HIS GLY LEU SEQRES 4 D 41 LYS ARG SEQRES 1 E 41 ASP SER SER ASP PRO LEU ALA VAL ALA ALA SER ILE ILE SEQRES 2 E 41 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 E 41 PHE PHE LYS SER ILE TYR ARG PHE PHE GLU HIS GLY LEU SEQRES 4 E 41 LYS ARG SEQRES 1 F 41 ASP SER SER ASP PRO LEU ALA VAL ALA ALA SER ILE ILE SEQRES 2 F 41 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 F 41 PHE PHE LYS SER ILE TYR ARG PHE PHE GLU HIS GLY LEU SEQRES 4 F 41 LYS ARG SEQRES 1 G 41 ASP SER SER ASP PRO LEU ALA VAL ALA ALA SER ILE ILE SEQRES 2 G 41 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 G 41 PHE PHE LYS SER ILE TYR ARG PHE PHE GLU HIS GLY LEU SEQRES 4 G 41 LYS ARG SEQRES 1 H 41 ASP SER SER ASP PRO LEU ALA VAL ALA ALA SER ILE ILE SEQRES 2 H 41 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 H 41 PHE PHE LYS SER ILE TYR ARG PHE PHE GLU HIS GLY LEU SEQRES 4 H 41 LYS ARG HET E01 D 101 16 HET E01 E 101 16 HETNAM E01 (1R,1'S,3'S,5'S,7'S)-SPIRO[CYCLOHEXANE-1,2'- HETNAM 2 E01 TRICYCLO[3.3.1.1~3,7~]DECAN]-4-AMINE FORMUL 9 E01 2(C15 H25 N) FORMUL 11 HOH *7(H2 O) HELIX 1 AA1 ASP A 24 TYR A 52 1 29 HELIX 2 AA2 PRO B 25 TYR B 52 1 28 HELIX 3 AA3 ASP C 24 ARG C 53 1 30 HELIX 4 AA4 ASP D 24 TYR D 52 1 29 HELIX 5 AA5 ASP E 24 ARG E 53 1 30 HELIX 6 AA6 ASP F 24 ARG F 53 1 30 HELIX 7 AA7 ASP G 24 PHE G 55 1 32 HELIX 8 AA8 ASP H 24 TYR H 52 1 29 SITE 1 AC1 6 ALA A 30 SER A 31 SER B 31 ALA C 30 SITE 2 AC1 6 ALA D 30 SER D 31 SITE 1 AC2 7 ALA E 30 SER E 31 ALA F 30 SER F 31 SITE 2 AC2 7 SER G 31 ALA H 30 SER H 31 CRYST1 49.420 49.380 122.380 90.00 90.00 90.00 P 21 21 2 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020235 0.000000 0.000000 0.00000 SCALE2 0.000000 0.020251 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008171 0.00000